• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - IRVINE TECHNOLOGY CENTER INFINITI VISION SYSTEM; UNIT, PHACOFRAGMENTATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - IRVINE TECHNOLOGY CENTER INFINITI VISION SYSTEM; UNIT, PHACOFRAGMENTATION Back to Search Results
Catalog Number 8065750833
Device Problems Decrease in Suction (1146); Energy Output Problem (1431); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Endophthalmitis (1835); Intraocular Pressure Increased (1937); Loss of Vision (2139); Vitreous Detachment (2445); Capsular Bag Tear (2639); Eye Pain (4467); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 11/08/2014
Event Type  Injury  
Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
 
Event Description
A legal entity reported this patient experienced endophthalmitis, choroidal detachment and phthisis of the left eyeball one month after cataract extraction procedure.The patient was hospitalized.Medication therapies were administered.The patient required an evisceration of the eye with prosthesis.This patient was previously reported to have experienced a posterior capsule tear during the original surgery, this event has been reported earlier in mfr # 2028159-2014-02051.
 
Manufacturer Narrative
The company service representative examined the system and no problems were found.The phaco handpiece and the cassette were tested and the tests were unremarkable.The system was then tested and met all product specifications.The surgeon refused to use the system.The company service representative replaced the fluidics module and ultrasound card as a diagnostic measure.The system was manufactured on july 17, 2012.Based on assessment, the product met specifications at the time of release.The system was found to meet specifications; therefore, the root cause of the reported event cannot be determined conclusively.The manufacturer internal reference number is: (b)(4).
 
Manufacturer Narrative
The manufacturer internal reference number is: (b)(4).
 
Event Description
Additional information has been received from the legal entity.It was reported that the cataract system had broken down, with weakness to no production of ultrasound and an imbalance between irrigation and aspiration.The anterior chamber shallowed and a posterior capsule tear occurred with vitreous prolapse.The handpiece and the cassette were exchanged but did not resolve the issue.A manual anterior vitrectomy had to be performed.An antibiotic was administered as preventative measure.The intraocular lens (iol) was implanted in front of the capsular bag.A suture was placed to seal the incision.Post operative day 1 the patient was prescribed a diuretic for treatment of intraocular hypertension.On that day there was no evidence of infection and no improvement to visual acuity.At 11 days post operative the patient was recommended to take an antibiotic for 1 month.At 1 month post operative visit the patient presented with swelling, redness, vision loss, pain and pus draining from the left eye.Aqueous sample was taken.A vitreous fragment was noted in the incision post operatively.It was noted that the patient had lost visual field on her left side, and continued deterioration to visual acuity.The patient experienced total blindness with enucleation of the eye.
 
Manufacturer Narrative
The manufacturer internal reference number is: (b)(4).
 
Manufacturer Narrative
The company representative was unable to confirm nor replicate the reported event.The system was tested and found to meet product specifications.A non-conformance based review of the serial number was performed and did not reveal any potential contributing factors to the reported complaint.A manufacturing device history record (dhr) review was performed prior to product release to ensure that the product was manufactured in compliance with the device master record.Based on the assessment, the product met release criteria.A review for complaints reported against this serial number was performed.No similar complaints were reported for the product serial under investigation.The system was found to meet specifications.Therefore, the root cause of the reported ¿poor ultrasound and unable to aspirate¿ is inconclusive.Based on the information obtained for the other reported events, the root causes were inconclusive.Manufacturer will continue to monitor data for evidence of adverse trending and take further action, as appropriate.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INFINITI VISION SYSTEM
Type of Device
UNIT, PHACOFRAGMENTATION
Manufacturer (Section D)
ALCON RESEARCH, LLC - IRVINE TECHNOLOGY CENTER
15800 alton parkway
irvine CA 92618
Manufacturer (Section G)
ALCON RESEARCH, LLC - IRVINE TECHNOLOGY CENTER
15800 alton parkway
irvine CA 92618
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key8154606
MDR Text Key130027856
Report Number2028159-2018-02580
Device Sequence Number1
Product Code HQC
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K120912
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Nurse
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 09/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number8065750833
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/17/2017
Initial Date FDA Received12/12/2018
Supplement Dates Manufacturer Received01/02/2019
03/07/2019
04/17/2023
08/09/2023
Supplement Dates FDA Received01/14/2019
03/19/2019
05/15/2023
09/07/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/17/2012
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
CUSTOM PAK, BEL.; DUOVISC IBC .5V/.55P CE-F.; SN60WF.210FX, ACRYSOF SP NATURAL IQ FX.; (B)(4), ACRYSOF SP NATURAL IQ FX; CUSTOM PAK, BEL; DUOVISC IBC .5V/.55P CE-F
Patient Outcome(s) Disability; Required Intervention; Hospitalization;
Patient Age82 YR
Patient SexFemale
Patient Weight73 KG
-
-